203 related articles for article (PubMed ID: 17270307)
21. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
[TBL] [Abstract][Full Text] [Related]
22. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
23. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
24. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
25. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
[TBL] [Abstract][Full Text] [Related]
26. Improved systemic delivery of insulin by condensed drug loading in a dimpled suppository.
Matsumoto A; Murakami K; Watanabe C; Murakami M
Drug Discov Ther; 2017; 11(6):293-299. PubMed ID: 29332886
[TBL] [Abstract][Full Text] [Related]
27. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
28. Spermine affects intestinal in vitro permeability to different-sized molecules in rats.
Osman NE; Weström B; Wang Q; Persson L; Karlsson B
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Aug; 120(2):211-6. PubMed ID: 9827034
[TBL] [Abstract][Full Text] [Related]
29. In situ ileal absorption of insulin in rats: effects of hyaluronidase pretreatment diminishing the mucous/glycocalyx layers.
Morishita M; Aoki Y; Sakagami M; Nagai T; Takayama K
Pharm Res; 2004 Feb; 21(2):309-16. PubMed ID: 15032313
[TBL] [Abstract][Full Text] [Related]
30. [Development of an oligoarginine peptide displaying rapid cell penetration for improved intestinal absorption].
Takayama K
Yakugaku Zasshi; 2014; 134(1):55-61. PubMed ID: 24389618
[TBL] [Abstract][Full Text] [Related]
31. Dependence of Intestinal Absorption Profile of Insulin on Carrier Morphology Composed of β-Cyclodextrin-Grafted Chitosan.
Daimon Y; Kamei N; Kawakami K; Takeda-Morishita M; Izawa H; Takechi-Haraya Y; Saito H; Sakai H; Abe M; Ariga K
Mol Pharm; 2016 Dec; 13(12):4034-4042. PubMed ID: 27749081
[TBL] [Abstract][Full Text] [Related]
32. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
33. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
34. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
[TBL] [Abstract][Full Text] [Related]
35. Spermined dextran, a cationized polymer, as absorption enhancer for pulmonary application of peptide drugs.
Morimoto K; Fukushi N; Chono S; Seki T; Tabata Y
Pharmazie; 2008 Mar; 63(3):180-4. PubMed ID: 18444505
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
37. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
38. Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy.
Kamei N; Shingaki T; Kanayama Y; Tanaka M; Zochi R; Hasegawa K; Watanabe Y; Takeda-Morishita M
Mol Pharm; 2016 Mar; 13(3):1004-11. PubMed ID: 26795701
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetic model of human insulin following different routes of administration.
Potocka E; Baughman RA; Derendorf H
J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
[TBL] [Abstract][Full Text] [Related]
40. Development of oligoarginine-drug conjugates linked to new peptidic self-cleavable spacers toward effective intestinal absorption.
Hayashi Y; Takayama K; Suehisa Y; Fujita T; Nguyen JT; Futaki S; Yamamoto A; Kiso Y
Bioorg Med Chem Lett; 2007 Sep; 17(18):5129-32. PubMed ID: 17662604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]